![Laura G. Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Laura G. Hansen
Investor Relations Contact chez
DENALI THERAPEUTICS INC.
Profil
Laura G.
Hansen currently works at Denali Therapeutics, Inc., as Vice President-Investor Relations from 2020.
Dr. Hansen also formerly worked at Corvas International, Inc., as Director-Corporate Communications from 2001 to 2002, Threshold Pharmaceuticals, Inc., as Senior Director-Corporate Communications, FibroGen, Inc., as Director-Corporate Communications from 2002 to 2012, Aimmune Therapeutics, Inc., as Vice President-Investor Relations from 2016 to 2019, and BlackThorn Therapeutics, Inc., as Vice President-Corporate Affairs from 2019 to 2020.
Dr. Hansen received her undergraduate degree and doctorate degree from The University of Texas at Austin.
Postes actifs de Laura G. Hansen
| Sociétés | Poste | Début |
|---|---|---|
| DENALI THERAPEUTICS INC. | Investor Relations Contact | 01/09/2020 |
Anciens postes connus de Laura G. Hansen
| Sociétés | Poste | Fin |
|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Corporate Officer/Principal | 01/09/2020 |
| AIMMUNE THERAPEUTICS, INC. | Investor Relations Contact | 01/03/2019 |
Threshold Pharmaceuticals, Inc.
 Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Investor Relations Contact | 01/02/2016 |
| KYNTRA BIO, INC. | Public Communications Contact | 01/07/2012 |
Corvas International, Inc.
 Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Public Communications Contact | 01/07/2002 |
Formation de Laura G. Hansen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Corvas International, Inc.
Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Threshold Pharmaceuticals, Inc.
Threshold Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
FibroGen, Inc.
 FibroGen, Inc. Pharmaceuticals: MajorHealth Technology Develops biotechnology-based drugs | Health Technology |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for neuron developmental disorders | Health Technology |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
